ChromaDex (CDXC) Misses Q1 EPS by 3c

Go back to ChromaDex (CDXC) Misses Q1 EPS by 3c

ChromaDex Corporation Reports First Quarter 2019 Financial Results

May 9, 2019 4:01 PM EDT

- First Quarter 2019 Net Revenues Increased by 53% to $10.0 Million -

First Quarter 2019 Highlights vs. First Quarter 2018

Strong start to the year with $10.0 million of net sales, higher gross margins and increased marketing efficiencyContinued progress building TRU NIAGEN into a global brand with top-line momentumTRU NIAGEN net sales were $7.5 million, a 15% increase sequentially and a 146% increase year-over-yearGlobal expansion continued with e-Commerce roll-out in Canada.  Set foundation for initial Canadian retail launch with Showcase and WELL Health Technologies in April

LOS ANGELES, May 09, 2019 (GLOBE NEWSWIRE)... More